Igene Biotechnology, Inc. (IGNE)

Vista Outdoor Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Net Income	-2.37	-0.14	-3.99	-1.9	-2.43	-2.04
Depreciation & Amortization	0.17	0.18	0.37	0.01	0.02	0.02
Other Amortization	0.01	0.01	1.29	1.41	1.28	0.62
Loss (Gain) From Sale of Assets	-	-	-	-0.01	-	0.11
Loss (Gain) on Equity Investments	1.73	1.09	-	0.11	0.11	0.37
Stock-Based Compensation	0.05	-	-	0.02	0.08	-
Other Operating Activities	-2.96	-3.34	0.01	0.01	0.01	0.38
Change in Accounts Receivable	0.03	1.04	1.67	-3.7	0.01	0.07
Change in Inventory	-0	2.4	5.66	1.81	-	-
Change in Accounts Payable	1.63	-1.33	-4.33	3.57	0.9	0.77
Change in Other Net Operating Assets	0.03	-0.02	0.01	-0.02	0.03	-0.01
Operating Cash Flow	-1.68	-0.1	0.71	1.31	0	0.29
Operating Cash Flow Growth	-	-	-46.16%	1310365.00%	-99.97%	-4.38%
Capital Expenditures	0.02	-0.17	-0.23	-0.28	-	-
Sale of Property, Plant & Equipment	0	-	-	0.02	-	-
Investment in Securities	-	-	-	-0.11	-0.11	-0.37
Investing Cash Flow	0.02	-0.17	-0.23	-0.36	-0.11	-0.37
Long-Term Debt Issued	-	-	-	0.76	-	-
Long-Term Debt Repaid	-	-	-	-0.71	-	-
Net Debt Issued (Repaid)	-	-	-	0.06	-	-
Issuance of Common Stock	-	-	-	-	0.01	-
Financing Cash Flow	-	-	-	0.06	0.01	-
Foreign Exchange Rate Adjustments	0.01	0.08	-0.02	-	-	-
Net Cash Flow	-1.65	-0.19	0.46	1	-0.1	-0.08
Free Cash Flow	-1.67	-0.27	0.48	1.04	0	0.29
Free Cash Flow Growth	-	-	-53.69%	1035285.00%	-99.97%	-4.38%
Free Cash Flow Margin	-34666.49%	-6.79%	6.27%	45.28%	-	-
Free Cash Flow Per Share	-0.00	-	0.00	0.01	-	0.00
Cash Interest Paid	-	-	-	0.06	0.04	0.09
Levered Free Cash Flow	-0.44	-0.21	1.1	-3.33	0.03	0.07
Unlevered Free Cash Flow	-0.41	-0.16	1.07	-3.36	0.07	0.37
Change in Net Working Capital	0.28	0.19	-2.3	3.16	-0.17	-0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.